July 26, 2022. MOBILion System Inc. (Chadds Ford, PA), a life science tools and instrumentation company commercializing a best-in-class technology to separate, identify, and analyze the most challenging molecules other instruments fail to detect, announced that it has appointed Jenn Buechel to serve on its...
Chadds Fords, PA, June 2, 2022: MOBILion Systems Inc. is teaming up with its industry partners including Agilent Technologies, and Protein Metrics, to deliver a series of educational events at the 70th Annual American Society for Mass Spectrometry (ASMS) conference being held June 5th to...
Chadds Fords, PA, October 26, 2021: MOBILion Systems Inc. will showcase its first commercial High-Resolution Ion Mobility (HRIM) product, MOBIE®, at the 69th Annual American Society for Mass Spectrometry (ASMS) conference. Taking place from October 31 to November 4, the conference is the first in-person...
July 13, 2021/Chadds Ford, PA - MOBILion Systems Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, today announced the close of a $60 million Series C financing round. The round was led by D1 Capital Partners with...
Chadds Fords, PA, June 15th, 2021: MOBILion Systems Inc. has today announced the launch of its first commercial High-Resolution Ion Mobility (HRIM) product, MOBIE, which addresses characterization challenges faced during biopharmaceutical drug development and quality monitoring. MOBIE provides fast, efficient separations with superior resolution and...
Protein Metrics (Cupertino, CA) and MOBILion Systems Inc. (Chadds Ford, PA) announce their strategic partnership to provide data analysis modules for Protein Metrics’ Byos software suite that work exclusively with MOBILion’s High-Resolution Ion Mobility (HRIM) Mass Spectrometry (MS) System. Combining best in class data analysis...
Chadds Fords, PA. -- MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early...
aMoon leads round to expand product portfolio and advance commercial efforts for MOBILion's SLIM technology for biotherapeutics characterization and novel biomarker discovery. Chadds Fords, PA. -- MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, today announced a $35...
Life Sciences Startup Touts Aggressive Milestones and Accelerates Strategic Growth Plan with Key Beta Users Including CCRC and Vanderbilt Chadds Fords, PA. -- MOBILion Systems, Inc., a pioneer in new instrumentation for biomarker discovery, diagnostics and therapeutic development, today announced its company highlights for first-half 2020. MOBILion Systems...
Chadds Fords, PA. -- MOBILion Systems, Inc., a pioneer in new instrumentation for biomarker discovery, diagnostics and therapeutic development, today announced it was named in a recent SelectScience article as one of the six top technology news stories, presented at the prestigious American Society for Mass Spectrometry conference, ASMS...